| scholarly article | Q13442814 |
| P2093 | author name string | Giovanna Tosato | |
| Gerald M Feldman | |||
| Yoshiyasu Aoki | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 1535-1542 | |
| P577 | publication date | 2002-10-03 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma | |
| P478 | volume | 101 |
| Q26741576 | A Central Role for STAT3 in Gammaherpesvirus-Life Cycle and -Diseases |
| Q33440392 | A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma. |
| Q33935165 | A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells |
| Q36894985 | A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells |
| Q35133375 | A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer |
| Q38948041 | A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells |
| Q37245887 | A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB. |
| Q36415707 | A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis |
| Q34452194 | Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis |
| Q39367196 | Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma |
| Q37644518 | Anti-cancer therapies that utilize cell penetrating peptides. |
| Q39399212 | Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway. |
| Q39752027 | Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells. |
| Q41817564 | Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways |
| Q41458660 | Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients. |
| Q33889920 | Association of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3) |
| Q39939644 | Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer |
| Q35660790 | B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation |
| Q35776979 | Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells |
| Q90419417 | Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma |
| Q38866915 | CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3. |
| Q36172819 | CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence |
| Q38286135 | Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression |
| Q35675995 | Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK. |
| Q33417870 | Characterization of STAT3 activation and expression in canine and human osteosarcoma |
| Q34695119 | Chemosensitization of tumors by resveratrol |
| Q37706702 | Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. |
| Q92377399 | Clinicopathological and Prognostic Role of STAT3/p-STAT3 in Breast Cancer Patients in China: A Meta-Analysis |
| Q35046691 | Combination of arsenic and interferon-α inhibits expression of KSHV latent transcripts and synergistically improves survival of mice with primary effusion lymphomas |
| Q47181709 | Constitutive activation of STAT3 and cyclin D1 overexpression contribute to proliferation, migration and invasion in gastric cancer cells |
| Q36882284 | Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis |
| Q36691086 | Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. |
| Q35840236 | Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis |
| Q36136572 | Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells |
| Q55060458 | Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro. |
| Q50677214 | Cucurbitacin B synergistically enhances the apoptosis-inducing effect of arsenic trioxide by inhibiting STAT3 phosphorylation in lymphoma Ramos cells. |
| Q34132787 | Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. |
| Q34555453 | Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity |
| Q24597686 | Cucurbitacins - a promising target for cancer therapy |
| Q40402530 | Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. |
| Q35190775 | Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways |
| Q92636408 | Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway |
| Q38264454 | Current status of treatment for primary effusion lymphoma |
| Q33586771 | DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis |
| Q37702744 | DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells. |
| Q64121016 | DNA methylation among firefighters |
| Q36588920 | Delivery of intracellular-acting biologics in pro-apoptotic therapies |
| Q39606399 | Dendritic cell differentiation blocked by primary effusion lymphoma-released factors is partially restored by inhibition of P38 MAPK. |
| Q34406374 | Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer |
| Q44906453 | Do Bcl-2 and survivin help distinguish benign from malignant B-cell lymphoid aggregates in bone marrow biopsies? |
| Q39498818 | Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth |
| Q39617609 | Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell lines |
| Q34467228 | Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy. |
| Q35891633 | Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation |
| Q41956511 | Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors |
| Q39034577 | Everolimus-induced human keratinocytes toxicity is mediated by STAT3 inhibition |
| Q34257818 | Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection |
| Q38114781 | Extolling the benefits of molecular therapeutic lipidation |
| Q34998646 | Function of survivin in trophoblastic cells of the placenta |
| Q39028862 | Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism |
| Q92354511 | G protein-coupled receptor kinase 2 regulating β2-adrenergic receptor signaling in M2-polarized macrophages contributes to hepatocellular carcinoma progression |
| Q40119306 | Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells |
| Q33779633 | Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling |
| Q33906033 | HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop |
| Q30389783 | Highly pathogenic avian influenza H5N1 virus delays apoptotic responses via activation of STAT3. |
| Q37250740 | Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo |
| Q38671885 | HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins |
| Q42202708 | Human herpesvirus 8 viral interleukin-6 signaling through gp130 promotes virus replication in primary effusion lymphoma and endothelial cells |
| Q33813244 | Human herpesvirus 8-encoded cytokines |
| Q35633069 | Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells |
| Q34568922 | IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin |
| Q39016421 | IL-7 receptor blockade inhibits IL-17-producing γδ cells and suppresses melanoma development |
| Q34016520 | ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex |
| Q61796834 | Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4 |
| Q34872523 | Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors. |
| Q104748100 | Induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic apoptotic pathways in primary effusion lymphoma |
| Q36485302 | Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells |
| Q35013694 | Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models |
| Q44559500 | Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma |
| Q39823619 | Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma |
| Q34094656 | Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells |
| Q41914515 | Inhibition of autophagy by chloroquine induces apoptosis in primary effusion lymphoma in vitro and in vivo through induction of endoplasmic reticulum stress |
| Q40294534 | Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells |
| Q38748837 | Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. |
| Q40024289 | Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells |
| Q42751427 | Inhibition of the signal transducers and activators of transcription (STAT) 3 signalling pathway by AG490 in laryngeal carcinoma cells |
| Q38614760 | Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression |
| Q35784760 | Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. |
| Q47099145 | JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B-Cell Lymphoma Growth by Increasing Apoptosis and Disrupting Cell Proliferation. |
| Q90162797 | KCP10043F Represses the Proliferation of Human Non-Small Cell Lung Cancer Cells by Caspase-Mediated Apoptosis via STAT3 Inactivation |
| Q42818551 | KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway |
| Q40046587 | Kaposi sarcoma herpesvirus pathogenesis. |
| Q37362933 | Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling |
| Q39665994 | Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency |
| Q43079558 | Kaposi's sarcoma-associated herpesvirus kaposin B induces unique monophosphorylation of STAT3 at serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28. |
| Q39833667 | Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene |
| Q40534487 | Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism |
| Q34125213 | Knock down of heat shock protein 27 (HspB1) induces degradation of several putative client proteins. |
| Q24802990 | Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells |
| Q40313907 | Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo |
| Q53161943 | Knockdown survivin expression reduces the efficacy of curcumin treatment in hepatocellular carcinoma cells. |
| Q37080996 | LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model |
| Q42071260 | Licking latency with licorice |
| Q34428326 | Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasion |
| Q28535017 | Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma |
| Q38820468 | MiR-506 functions as a tumor suppressor in glioma by targeting STAT3. |
| Q34113375 | MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts |
| Q39017730 | Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression |
| Q37010787 | Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3. |
| Q40290658 | Mogrol represents a novel leukemia therapeutic, via ERK and STAT3 inhibition. |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q92538749 | Molecular Insight Into the IRE1α-Mediated Type I Interferon Response Induced by Proteasome Impairment in Myeloid Cells of the Brain |
| Q34013830 | Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication |
| Q36763730 | Molecular evidence of cryptotanshinone for treatment and prevention of human cancer |
| Q40144368 | Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma |
| Q47131885 | Myocardin and Stat3 act synergistically to inhibit cardiomyocyte apoptosis |
| Q37302750 | New wirings in the survivin networks |
| Q38864169 | Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer |
| Q30493841 | Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells |
| Q39571277 | Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells |
| Q40068733 | Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin |
| Q39921137 | Oct4 is expressed in human gliomas and promotes colony formation in glioma cells |
| Q35199327 | Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance |
| Q51499892 | PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition. |
| Q40203795 | PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells |
| Q35110909 | Pathogenesis and manifestations of human herpesvirus-8-associated disorders |
| Q35179783 | Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection |
| Q43478901 | Pentraxin 3 inhibits acute renal injury-induced interstitial fibrosis through suppression of IL-6/Stat3 pathway |
| Q40536305 | Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells |
| Q35784707 | Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. |
| Q24299259 | Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA |
| Q38300255 | Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. |
| Q34786411 | Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1. |
| Q28481417 | Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91 |
| Q38194434 | Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature |
| Q41507351 | Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy |
| Q38987923 | Quercetin potentiates the antitumor activity of rituximab in diffuse large B-cell lymphoma by inhibiting STAT3 pathway |
| Q35987390 | Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells |
| Q40251046 | Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma |
| Q28484266 | Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells |
| Q42052945 | Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability |
| Q39769098 | Runx2 regulates survivin expression in prostate cancer cells |
| Q40250970 | SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells |
| Q39359156 | SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma |
| Q35911116 | STAT proteins as novel targets for cancer drug discovery |
| Q34306802 | STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer |
| Q38671957 | STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications |
| Q38838049 | STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus. |
| Q28299368 | STAT3 as a therapeutic target in head and neck cancer |
| Q40568079 | STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. |
| Q90924602 | STAT3 phosphorylation affects p53/p21 axis and KSHV lytic cycle activation |
| Q58716603 | STAT3 promotes tumour progression in glioma by inducing FOXP1 transcription |
| Q36130808 | STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation |
| Q50915651 | Screening of Stat3 inhibitory effects of Korean herbal medicines in the A549 human lung cancer cell line. |
| Q43665317 | Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma |
| Q38994020 | Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma |
| Q35673818 | Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis |
| Q37869903 | Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy |
| Q35120899 | Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. |
| Q35221996 | Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer. |
| Q36246709 | Silencing STAT3 with short hairpin RNA enhances radiosensitivity of human laryngeal squamous cell carcinoma xenografts in vivo |
| Q40162481 | Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells |
| Q33986325 | Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis |
| Q41479802 | Stat3 as a potential therapeutic target for rheumatoid arthritis. |
| Q37643955 | Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression |
| Q38326252 | Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target |
| Q37156393 | Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer |
| Q33749658 | Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells |
| Q24674087 | Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma |
| Q39755316 | Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways |
| Q26766250 | Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies |
| Q35844066 | Survivin expression in tuberous sclerosis complex cells |
| Q37974867 | Survivin in solid tumors: rationale for development of inhibitors. |
| Q37598765 | Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors |
| Q37271051 | Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3. |
| Q37340201 | Survivin mediates renal proximal tubule recovery from AKI. |
| Q35992790 | Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells |
| Q33634679 | Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. |
| Q35591693 | Survivin, versatile modulation of cell division and apoptosis in cancer |
| Q35959085 | Survivin: a bifunctional inhibitor of apoptosis protein |
| Q36396623 | Tanshinones: sources, pharmacokinetics and anti-cancer activities |
| Q90292397 | Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges |
| Q58552304 | Targeting Upstream Kinases of STAT3 in Human Medulloblastoma cells |
| Q54188941 | Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma. |
| Q26821986 | Targeting caspases in cancer therapeutics |
| Q28081199 | Targeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and Future |
| Q35071118 | The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells |
| Q92619559 | The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models |
| Q30008930 | The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA. |
| Q29614601 | The STATs of cancer--new molecular targets come of age |
| Q36583525 | The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition |
| Q34605234 | The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac |
| Q64092190 | The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells |
| Q42754872 | The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin |
| Q33729093 | The reactive oxygen species–Src–Stat3 pathway provokes negative feedback inhibition of apoptosis induced by high‐fluence low‐power laser irradiation |
| Q49990319 | The role of STAT3 in leading the crosstalk between human cancers and the immune system |
| Q38211079 | The role of inflammation in kidney cancer |
| Q38770247 | The role of octamer binding transcription factors in glioblastoma multiforme |
| Q39672712 | The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection |
| Q33883721 | The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells |
| Q36301932 | The twisted survivin connection to angiogenesis |
| Q33293430 | Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice |
| Q35917368 | Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders |
| Q96305503 | Unbiased analysis of peripheral blood mononuclear cells reveals CD4 T cell response to RSV matrix protein |
| Q28201382 | Validating survivin as a cancer therapeutic target |
| Q35475660 | Variants of SCARB1 and VDR Involved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell Carcinoma |
| Q38188591 | Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies |
| Q37593352 | Viral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses |
| Q35769723 | cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours |
| Q38308505 | hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes |
| Q34236653 | γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents |
Search more.